Comparison of point-of-care-testing glucose meters with standard laboratory measurement of the 50g-glucose-challenge test (GCT) during pregnancy.

OBJECTIVES Although glucose meters are well-established instruments for self-monitoring blood glucose levels, diagnostic and screening procedures should be performed using standard laboratory methods. In addition to standard laboratory methods, HemoCue is authorized for screening and diagnostic purposes in Germany. The rapid development of other glucose meters makes it necessary to re-evaluate this recommendation. Our objective was to test the usefulness of glucose meters in screening pregnant patients for gestational diabetes. METHODS The 50-g glucose challenge test was administered to one hundred and ninety-three pregnant patients whose blood glucose levels were then simultaneously measured with five portable meters and the HemoCue. The results were compared to our standard method (Hexokinase). A cut-off of 7.8 mmol/L was used and sensitivity, specificity, accuracy, the Youden index, and the Kappa index were calculated. The tests were performed by well-trained personnel (C.D. and U.S.). RESULTS 1212 measurements were performed on 193 patients. All glucose meters showed a very good correlation (r > 0.90). None of the measurements showed an extreme deviation necessitating the error grid analysis. The GlucoTouch (5.93% +/- 7.4) and the HemoCue (-9.04% +/- 5.9) showed a mean deviation greater than 5%. None of the meters had a mean deviation greater than 10%. The accuracy fluctuated between 0.85 and 0.94. The Kappa index was between 66 to 85. In our clinical trial, the Accu-Chek, Glucotouch, OneTouch, and Precision demonstrated greater accuracy and a higher Kappa index than the HemoCue. CONCLUSIONS Our data showed good concordance in statistical and clinical parameters for most of the six glucose meters. The HemoCue, recommended as a standard method in several countries, did not show better concordance than most of the tested glucose meters. When used by well-trained personnel, the accuracy of the Accu-Chek, Glucotouch, One-Touch, and Precision was acceptable for use in gestational diabetes screening.

[1]  K. Wiener Whole Blood Glucose: What are We Actually Measuring? , 1995, Annals of clinical biochemistry.

[2]  S. Carr,et al.  Precision of office-based blood glucose meters in screening for gestational diabetes. , 1995, American Journal of Obstetrics and Gynecology.

[3]  A. Karter,et al.  Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. , 2000, Diabetes care.

[4]  M. Fraser,et al.  The relationship between capillary and venous glucose concentration during pregnancy. , 1986, American journal of obstetrics and gynecology.

[5]  J. Nichols,et al.  Technical evaluation of five glucose meters with data management capabilities. , 1999, American journal of clinical pathology.

[6]  R. Weitgasser,et al.  Newer portable glucose meters--analytical improvement compared with previous generation devices? , 1999, Clinical chemistry.

[7]  S. Carr,et al.  Precision of Reflectance Meters in Screening for Gestational Diabetes , 1989, Obstetrics and gynecology.

[8]  P. St-Louis Status of point-of-care testing: promise, realities, and possibilities. , 2000, Clinical biochemistry.

[9]  P Wach,et al.  Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches , 1998, Diabetes Care.

[10]  Evaluation of the Abbott PCx (R) point of care glucose analyzer in a pediatric hospital. , 2000, Clinical biochemistry.

[11]  S. Gabbe,et al.  Capillary blood glucose screening for gestational diabetes: a preliminary investigation. , 1986, American journal of obstetrics and gynecology.